GlassScriptPhysician profile
Ameer Kabour
NPI 1861485104
$16,248.37
in general payments reported to CMS, 2019-2025
53 companies · $374 in 2025
The $374 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,954 · 2020: $2,332 · 2021: $3,552 · 2022: $3,611 · 2023: $2,040 · 2024: $385 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,798.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,536.07 | 2021-2025 | Onyx Frontier, Launcher, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $1,884.03 | 2019-2023 | Xarelto |
| Abbott Laboratories | $1,212.38 | 2019-2025 | Mitraclip, Amplatzer Talisman, Xience Skypoint |
| Astrazeneca Pharmaceuticals LP | $1,123.87 | 2019-2023 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $1,064.66 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $891.38 | 2019-2023 | Jardiance |
| Medtronic Vascular, INC. | $794.21 | 2019-2020 | |
| Amgen INC. | $611.46 | 2019-2023 | Repatha |
| Pfizer INC. | $585.16 | 2019-2023 | |
| Amarin Pharma, INC. | $468.15 | 2019-2022 | |
| Esperion Therapeutics, INC. | $419.00 | 2020-2022 | |
| Shockwave Medical, INC | $359.86 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $340.13 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $306.19 | 2021-2023 | Verquvo |
| Abiomed | $274.24 | 2019-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $254.82 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $223.05 | 2019-2021 | |
| Chiesi USA, INC. | $222.92 | 2019-2022 | |
| Novo Nordisk INC | $216.35 | 2019 | |
| Kestra Medical Technology Services, INC. | $216.08 | 2023 | Assure Wcd |
| Inari Medical, INC. | $204.28 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astellas Pharma US INC | $201.90 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $200.46 | 2019-2023 | Eliquis, Camzyos |
| Boston Scientific Corporation | $185.47 | 2023-2024 | Watchman Flx, Watchman Access System |
| Actelion Pharmaceuticals US, INC. | $154.00 | 2020-2023 | Uptravi, Opsumit |
| Cardiovascular Systems INC. | $123.71 | 2020-2023 | Diamondback Coronary |
| Irhythm Technologies, INC. | $119.56 | 2022 | |
| Cardiva Medical, INC. | $117.10 | 2019-2023 | |
| Janssen Scientific Affairs, LLC | $104.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $101.34 | 2020-2021 | |
| Biotronik INC. | $95.99 | 2019-2022 | |
| Penumbra, INC. | $95.78 | 2022 | |
| Impulse Dynamics (USA) INC. | $65.20 | 2024 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $45.46 | 2019 | |
| Cordis US Corp. | $43.00 | 2025 | Mynxgrip |
| Cvrx, INC. | $35.86 | 2020 | |
| Stryker Corporation | $32.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alnylam Pharmaceuticals INC. | $32.25 | 2022-2023 | Onpattro |
| Lexicon Pharmaceuticals, INC. | $32.16 | 2023 | Inpefa |
| Biosense Webster, INC. | $31.92 | 2023 | Na |
| Philips North America LLC | $28.99 | 2022-2023 | |
| Lundbeck LLC | $27.10 | 2019-2020 | |
| Csl Behring | $25.60 | 2022 | |
| Celonova Biosciences, INC. | $21.33 | 2019 | |
| Zoll Circulation INC | $18.67 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Bridgebio Pharma, INC. | $16.96 | 2025 | Attruby |
| Terumo Medical Corporation | $16.80 | 2021 | |
| Teleflex LLC | $15.44 | 2023 | Pronto |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Amryt Pharma Holdings LTD | $14.47 | 2021 | |
| Allergan, INC. | $11.94 | 2019 | |
| Elutia, INC. | $9.59 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameer Kabour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.